These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15320777)

  • 1. Urocortins: take them to heart.
    Scarabelli T; Knight R
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Oct; 2(4):335-342. PubMed ID: 15320777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urocortin: molecular biology and cardiovascular effects].
    Raddino R; Pedrinazzi C; Zanini G; Robba D; Bonadei I; Scarabelli TM; Cas LD
    G Ital Cardiol (Rome); 2007 Apr; 8(4):236-45. PubMed ID: 17506295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family.
    Davidson SM; Rybka AE; Townsend PA
    Biochem Pharmacol; 2009 Jan; 77(2):141-50. PubMed ID: 18817752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective and Vasoprotective Effects of Corticotropin-Releasing Hormone and Urocortins: Receptors and Signaling.
    Popov SV; Prokudina ES; Mukhomedzyanov AV; Naryzhnaya NV; Ma H; Zurmanova JM; der Ven PFMV; Maslov LN
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):575-584. PubMed ID: 34351805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular actions of CRH and urocortin: an update.
    Parkes DG; Weisinger RS; May CN
    Peptides; 2001 May; 22(5):821-7. PubMed ID: 11337096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
    Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
    Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin and cardiovascular protection.
    Huang Y; Yao XQ; Lau CW; Chan YC; Tsang SY; Chan FL
    Acta Pharmacol Sin; 2004 Mar; 25(3):257-65. PubMed ID: 15000874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardioprotective effect of urocortin during ischaemia/reperfusion involves the prevention of mitochondrial damage.
    Lawrence KM; Townsend PA; Davidson SM; Carroll CJ; Eaton S; Hubank M; Knight RA; Stephanou A; Latchman DS
    Biochem Biophys Res Commun; 2004 Aug; 321(2):479-86. PubMed ID: 15358201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing hormone-related peptides and receptors: emergent regulators of cardiovascular adaptations to stress.
    Coste SC; Quintos RF; Stenzel-Poore MP
    Trends Cardiovasc Med; 2002 May; 12(4):176-82. PubMed ID: 12069758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of urocortins in the cardiovascular system.
    Walczewska J; Dzieza-Grudnik A; Siga O; Grodzicki T
    J Physiol Pharmacol; 2014 Dec; 65(6):753-66. PubMed ID: 25554979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRH-like peptides protect cardiac myocytes from lethal ischaemic injury.
    Brar BK; Stephanou A; Okosi A; Lawrence KM; Knight RA; Marber MS; Latchman DS
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):55-63. PubMed ID: 10630405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warm blood cardioplegic arrest induces mitochondrial-mediated cardiomyocyte apoptosis associated with increased urocortin expression in viable cells.
    Scarabelli TM; Pasini E; Ferrari G; Ferrari M; Stephanou A; Lawrence K; Townsend P; Chen-Scarabelli C; Gitti G; Saravolatz L; Latchman D; Knight RA; Gardin JM
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):364-71. PubMed ID: 15354093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urocortin.
    Latchman DS
    Int J Biochem Cell Biol; 2002 Aug; 34(8):907-10. PubMed ID: 12007627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warm-blood cardioplegic arrest induces selective mitochondrial translocation of protein kinase Cepsilon followed by interaction with 6.1 inwardly rectifying potassium channel subunit in viable myocytes overexpressing urocortin.
    Chen-Scarabelli C; Faggian G; Yuan Z; Tessari M; Rungatscher A; Di Rezze J; Scarabelli GM; Abounit K; McCauley R; Saravolatz L; Mazzucco A; Scarabelli TM
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1213-21. PubMed ID: 19660384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urocortin inhibits Beclin1-mediated autophagic cell death in cardiac myocytes exposed to ischaemia/reperfusion injury.
    Valentim L; Laurence KM; Townsend PA; Carroll CJ; Soond S; Scarabelli TM; Knight RA; Latchman DS; Stephanou A
    J Mol Cell Cardiol; 2006 Jun; 40(6):846-52. PubMed ID: 16697404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection mediated by urocortin is dependent on PKCepsilon activation.
    Lawrence KM; Kabir AM; Bellahcene M; Davidson S; Cao XB; McCormick J; Mesquita RA; Carroll CJ; Chanalaris A; Townsend PA; Hubank M; Stephanou A; Knight RA; Marber MS; Latchman DS
    FASEB J; 2005 May; 19(7):831-3. PubMed ID: 15764590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors.
    Wei ET; Thomas HA; Christian HC; Buckingham JC; Kishimoto T
    Peptides; 1998; 19(7):1183-90. PubMed ID: 9786168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins.
    Grammatopoulos DK; Randeva HS; Levine MA; Katsanou ES; Hillhouse EW
    Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urocortin protects cardiac myocytes from ischemia/reperfusion injury by attenuating calcium-insensitive phospholipase A2 gene expression.
    Lawrence KM; Scarabelli TM; Turtle L; Chanalaris A; Townsend PA; Carroll CJ; Hubank M; Stephanou A; Knight RA; Latchman DS
    FASEB J; 2003 Dec; 17(15):2313-5. PubMed ID: 14563694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urocortin increases the expression of heat shock protein 90 in rat cardiac myocytes in a MEK1/2-dependent manner.
    Brar BK; Railson J; Stephanou A; Knight RA; Latchman DS
    J Endocrinol; 2002 Feb; 172(2):283-93. PubMed ID: 11834446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.